Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0760
+0.0005 (0.66%)
Mar 11, 2026, 2:44 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 91.14 million as of March 11, 2026. Its market cap has decreased by -36.56% in one year.
Market Cap
91.14M
Enterprise Value
71.78M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 91.14M, an increase of 415.66%. That is a compound annual growth rate of 7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 91.14M | -18.41% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 125.79M |
| Botanix Pharmaceuticals | 122.00M |
| Paradigm Biopharmaceuticals | 114.21M |
| LTR Pharma | 83.62M |
| Cynata Therapeutics | 78.36M |
| Radiopharm Theranostics | 77.97M |
| Alterity Therapeutics | 76.13M |
| Imugene | 73.95M |